US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Toyota

197.35

+5.112.66%

Post-market: 197.34-0.0100-0.01%19:59 EDT

Volume:369.07K

Turnover:72.85M

Market Cap:233.66B

PE:9.18

High:198.00

Open:196.63

Low:196.63

Close:192.24

52wk High:248.90

52wk Low:166.10

Shares:1.18B

Float Shares:1.09B

Volume Ratio:1.24

T/O Rate:0.03%

Dividend:5.98

Dividend Rate:3.03%

EPS(TTM):21.49

EPS(LYR):18.57

ROE:12.40%

ROA:2.34%

PB:1.00

PE(LYR):10.63

Loading ...

Overview Company News Filings

Press Release: Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

Press Release: Cerenome Reports Second Quarter 2026 Financial Results and Business Update

Press Release: Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026

Press Release: Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives Growth

Press Release: Quoin Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Press Release: Evaxion to Announce Business Update and Second Quarter 2026 Financial Results on August 20, 2026

Press Release: Lantern Pharma Reports Second Quarter 2026 Financial Results and Provides Business Update

Press Release: Milestone Scientific Reports Financial Results for Second Quarter 2026

Press Release: Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights

Press Release: Payward Reports Second Quarter 2026 Adjusted Revenue of $508 Million, up 17% Year over Year

Press Release: Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial

Press Release: BTQ Technologies Announces 2026 AGM Results

Press Release: Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates

Press Release: Tri Pointe Homes, Inc. Reports 2026 Second Quarter Results

Press Release: Xos Extends Gross Profit Streak, Highlighting Operational Efficiency

Press Release: Celcuity Inc. Reports Release of Second Quarter 2026 Financial Results and Provides Corporate Update

Press Release: Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus(TM) Development Update

Press Release: Swarmer Reports Second Quarter 2026 Financial Results and Provides Business Update

Press Release: Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update

Press Release: Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/TM/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TM\",,,,,undefined,":{"symbol":"TM","market":"US","secType":"STK","nameCN":"Toyota","latestPrice":197.35,"timestamp":1787342400000,"preClose":192.24,"halted":0,"volume":369066,"hourTrading":{"tag":"盘后","latestPrice":197.34,"preClose":197.35,"latestTime":"19:59 EDT","volume":1890,"amount":372849.7428,"timestamp":1787356758364,"change":-0.01,"changeRate":-0.000051,"amplitude":0.000051},"delay":0,"changeRate":0.026581356637536333,"floatShares":1091996400,"shares":1184000000,"eps":21.492434,"marketStatus":"Market Closed","change":5.11,"latestTime":"08-21 16:00:00 EDT","open":196.63,"high":198,"low":196.63,"amount":72854425.58256,"amplitude":0.007127,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":21.492434,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":1,"adrRate":10,"listingDate":938577600000,"exchange":"NYSE","adjPreClose":192.24,"dividendRate":0.030505,"preHourTrading":{"tag":"盘前","latestPrice":196.55,"preClose":192.24,"latestTime":"09:29 EDT","volume":3200,"amount":629103.0399999999,"timestamp":1787318991075,"change":4.31,"changeRate":0.02242,"amplitude":0.028678},"postHourTrading":{"tag":"盘后","latestPrice":197.34,"preClose":197.35,"latestTime":"19:59 EDT","volume":1890,"amount":372849.7428,"timestamp":1787356758364,"change":-0.01,"changeRate":-0.000051,"amplitude":0.000051},"volumeRatio":1.2380369656487134,"impliedVol":0.2419,"impliedVolPercentile":0.0837},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TM\",,,,,undefined,":{"symbol":"TM","floatShares":1091996400,"roa":"2.34%","roe":"12.40%","lyrEps":18.568556,"volumeRatio":1.2380369656487134,"shares":1184000000,"dividePrice":5.97645,"high":198,"amplitude":0.007127,"preClose":192.24,"low":196.63,"week52Low":166.1,"pbRate":"1.00","psRate":"0.71","week52High":248.9,"institutionHeld":0.1801,"latestPrice":197.35,"eps":21.492434,"divideRate":0.030284,"volume":369066,"delay":0,"ttmEps":21.492434,"open":196.63,"prevYearClose":214.06,"prevWeekClose":191.11,"prevMonthClose":188.99,"prevQuarterClose":168.42,"fiveDayClose":191.11,"twentyDayClose":177.42,"sixtyDayClose":190.11,"dividendPayoutRate":1.3265738484248728,"dividendGrowthYears":0,"dividendGrowthRate":-0.5603196929755107,"fiveYearAvgDividendRate":0.022280239884563},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"TM","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"pre","actualEps":7.57},{"market":"US","date":"2026-05-08","symbol":"TM","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"pre","actualEps":4},{"date":"2026-02-06","symbol":"TM","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770368400000,"name":null,"time":"Pre-MKt","dateTimestamp":1770354000000,"actualEps":null},{"market":"US","date":"2025-11-05","symbol":"TM","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":4.85},{"market":"US","date":"2025-08-07","symbol":"TM","fiscalQuarterEnding":"2025/06","expectedEps":4.67,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":4.47}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TM\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-28","recordDate":"2016-09-30","paymentDate":"2016-12-09","value":1.569363,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5,"hold":0,"sell":0.1667,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":6,"updateTime":1778817600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TM","date":"2026-08-21","current":9.182301,"percent":0.193955,"low":5.801283,"twenty":8.315982,"median":9.643002,"eighty":10.611709,"high":13.909472,"avg":9.497569,"sd":1.47721,"marketCap":233618820103.18},"quantilePoints":[{"date":"2021-08-27","current":8.830772,"twenty":8.386407,"median":10.009884,"eighty":12.026178,"marketCap":239731757268.03},{"date":"2021-09-03","current":9.063413,"twenty":8.393326,"median":10.004604,"eighty":12.01051,"marketCap":246637389214.94},{"date":"2021-09-10","current":9.252002,"twenty":8.394908,"median":10.002518,"eighty":12.004072,"marketCap":251288150621.92},{"date":"2021-09-17","current":9.308671,"twenty":8.396048,"median":9.99775,"eighty":11.994408,"marketCap":252799709406.21},{"date":"2021-09-24","current":9.382992,"twenty":8.403792,"median":9.986261,"eighty":11.987415,"marketCap":252923794576.82},{"date":"2021-10-01","current":9.12927,"twenty":8.409387,"median":9.973917,"eighty":11.971261,"marketCap":245304629508.38},{"date":"2021-10-08","current":8.925056,"twenty":8.410028,"median":9.964878,"eighty":11.960601,"marketCap":237531091007.3},{"date":"2021-10-15","current":9.252262,"twenty":8.428607,"median":9.962049,"eighty":11.82452,"marketCap":241843777339.12},{"date":"2021-10-22","current":9.20585,"twenty":8.440923,"median":9.952345,"eighty":11.645716,"marketCap":241593442858.66},{"date":"2021-10-29","current":9.312598,"twenty":8.443706,"median":9.948053,"eighty":11.561919,"marketCap":243634285432.24},{"date":"2021-11-05","current":8.975461,"twenty":8.445805,"median":9.935016,"eighty":11.532678,"marketCap":248501922540.45},{"date":"2021-11-12","current":9.16732,"twenty":8.454705,"median":9.910445,"eighty":11.523333,"marketCap":252793124084.94},{"date":"2021-11-19","current":9.405489,"twenty":8.461877,"median":9.899061,"eighty":11.517377,"marketCap":259527117928.35},{"date":"2021-11-26","current":9.149677,"twenty":8.466559,"median":9.894628,"eighty":11.512447,"marketCap":253479623869.98},{"date":"2021-12-03","current":9.160058,"twenty":8.475021,"median":9.887521,"eighty":11.505169,"marketCap":254400083471.97},{"date":"2021-12-10","current":9.041096,"twenty":8.480033,"median":9.88412,"eighty":11.493229,"marketCap":250566573719.52},{"date":"2021-12-17","current":9.263599,"twenty":8.484548,"median":9.86767,"eighty":11.48171,"marketCap":256097965039.75},{"date":"2021-12-23","current":9.237163,"twenty":8.490174,"median":9.859408,"eighty":11.471221,"marketCap":253647768358.79},{"date":"2021-12-31","current":9.276817,"twenty":8.493551,"median":9.854997,"eighty":11.456034,"marketCap":253024211561.73},{"date":"2022-01-07","current":10.166827,"twenty":8.496303,"median":9.855048,"eighty":11.431774,"marketCap":276004685092.89},{"date":"2022-01-14","current":10.516828,"twenty":8.503793,"median":9.859806,"eighty":11.425102,"marketCap":290098154445},{"date":"2022-01-21","current":10.052591,"twenty":8.517735,"median":9.870881,"eighty":11.424469,"marketCap":277446097986.58},{"date":"2022-01-28","current":9.843575,"twenty":8.539835,"median":9.860203,"eighty":11.409941,"marketCap":268403226005.71},{"date":"2022-02-04","current":10.011773,"twenty":8.541824,"median":9.870881,"eighty":11.399135,"marketCap":272821257021.9},{"date":"2022-02-11","current":10.058874,"twenty":8.54339,"median":9.88412,"eighty":11.396131,"marketCap":268450027193.42},{"date":"2022-02-18","current":9.746486,"twenty":8.54339,"median":9.859806,"eighty":11.396131,"marketCap":261873033011.99},{"date":"2022-02-25","current":9.389472,"twenty":8.54339,"median":9.853459,"eighty":11.396131,"marketCap":251241883575.67},{"date":"2022-03-04","current":8.799364,"twenty":8.54339,"median":9.845856,"eighty":11.396131,"marketCap":237284744492.84},{"date":"2022-03-11","current":8.288067,"twenty":8.499307,"median":9.844533,"eighty":11.396131,"marketCap":218913247941.31},{"date":"2022-03-18","current":8.9986,"twenty":8.499307,"median":9.836624,"eighty":11.396131,"marketCap":233634975165.39},{"date":"2022-03-25","current":9.75293,"twenty":8.499307,"median":9.828189,"eighty":11.396131,"marketCap":247249672929.23},{"date":"2022-04-01","current":9.824217,"twenty":8.499307,"median":9.828189,"eighty":11.396131,"marketCap":247460850931.08},{"date":"2022-04-08","current":9.334918,"twenty":8.499307,"median":9.831145,"eighty":11.396131,"marketCap":232235123302.67},{"date":"2022-04-14","current":9.495289,"twenty":8.499307,"median":9.831145,"eighty":11.396131,"marketCap":233257145582.12},{"date":"2022-04-22","current":9.844986,"twenty":8.499307,"median":9.839797,"eighty":11.396131,"marketCap":236599907147.33},{"date":"2022-04-29","current":9.958582,"twenty":8.499307,"median":9.840723,"eighty":11.396131,"marketCap":237347675531.69},{"date":"2022-05-06","current":10.138999,"twenty":8.499307,"median":9.845088,"eighty":11.396131,"marketCap":240796093234.38},{"date":"2022-05-13","current":9.902689,"twenty":8.499307,"median":9.845841,"eighty":11.396131,"marketCap":218406153199.98},{"date":"2022-05-20","current":9.868957,"twenty":8.499307,"median":9.850202,"eighty":11.396131,"marketCap":219985877217.54},{"date":"2022-05-27","current":10.042435,"twenty":8.499307,"median":9.857177,"eighty":11.396131,"marketCap":225205518526.56},{"date":"2022-06-03","current":10.43276,"twenty":8.499307,"median":9.871524,"eighty":11.396131,"marketCap":227442854072.09},{"date":"2022-06-10","current":10.618285,"twenty":8.499307,"median":9.881378,"eighty":11.396131,"marketCap":225527280701.5},{"date":"2022-06-17","current":9.94124,"twenty":8.499307,"median":9.886852,"eighty":11.396131,"marketCap":209613208799.02},{"date":"2022-06-24","current":10.174953,"twenty":8.498306,"median":9.898721,"eighty":11.396882,"marketCap":214650672075.96},{"date":"2022-07-01","current":9.960515,"twenty":8.498306,"median":9.910445,"eighty":11.396882,"marketCap":209955949125.43},{"date":"2022-07-08","current":10.16347,"twenty":8.498306,"median":9.925171,"eighty":11.396882,"marketCap":212820567269.74},{"date":"2022-07-15","current":10.413825,"twenty":8.498306,"median":9.925171,"eighty":11.396882,"marketCap":214317007818.47},{"date":"2022-07-22","current":10.603999,"twenty":8.498306,"median":9.94124,"eighty":11.396882,"marketCap":222014152586.22},{"date":"2022-07-29","current":10.288648,"twenty":8.498306,"median":9.950148,"eighty":11.396882,"marketCap":219757471716.45},{"date":"2022-08-05","current":10.806112,"twenty":8.498306,"median":9.958582,"eighty":11.396882,"marketCap":214624780320.42},{"date":"2022-08-12","current":10.867192,"twenty":8.498306,"median":9.962049,"eighty":11.396882,"marketCap":218729696330.85},{"date":"2022-08-19","current":10.943542,"twenty":8.498306,"median":9.99775,"eighty":11.396882,"marketCap":214673171486.83},{"date":"2022-08-26","current":10.729761,"twenty":8.498306,"median":10.002981,"eighty":11.396882,"marketCap":210252561069.66},{"date":"2022-09-02","current":10.42945,"twenty":8.498306,"median":10.009884,"eighty":11.396882,"marketCap":200204255509.37},{"date":"2022-09-09","current":10.579606,"twenty":8.498306,"median":10.023176,"eighty":11.396882,"marketCap":199607069481.08},{"date":"2022-09-16","current":10.335285,"twenty":8.498306,"median":10.032798,"eighty":11.396882,"marketCap":194372829865.35},{"date":"2022-09-23","current":10.32256,"twenty":8.498306,"median":10.032798,"eighty":11.396882,"marketCap":193831215549.25},{"date":"2022-09-30","current":9.548877,"twenty":8.498306,"median":10.023176,"eighty":11.396882,"marketCap":177471819946.95},{"date":"2022-10-07","current":10.106181,"twenty":8.498306,"median":10.02316,"eighty":11.396882,"marketCap":187164770352.11},{"date":"2022-10-14","current":10.220706,"twenty":8.498306,"median":10.012625,"eighty":11.396882,"marketCap":185125554677.98},{"date":"2022-10-21","current":10.116361,"twenty":8.498306,"median":10.012625,"eighty":11.396882,"marketCap":183586764747.77},{"date":"2022-10-28","current":10.332686,"twenty":8.498306,"median":10.012625,"eighty":11.396882,"marketCap":188355275218.58},{"date":"2022-11-04","current":10.847885,"twenty":8.498306,"median":10.012625,"eighty":11.396882,"marketCap":184044729352.68},{"date":"2022-11-11","current":10.935324,"twenty":8.498306,"median":10.012625,"eighty":11.396882,"marketCap":196172673768.74},{"date":"2022-11-18","current":10.891604,"twenty":8.498306,"median":10.012625,"eighty":11.396882,"marketCap":194342479643.61},{"date":"2022-11-25","current":11.227697,"twenty":8.498306,"median":10.012625,"eighty":11.396882,"marketCap":201352566176.83},{"date":"2022-12-02","current":10.771376,"twenty":8.498306,"median":10.012625,"eighty":11.396882,"marketCap":198720186497.14},{"date":"2022-12-09","current":10.672344,"twenty":8.498306,"median":10.012625,"eighty":11.396882,"marketCap":195394464280.42},{"date":"2022-12-16","current":10.601341,"twenty":8.498306,"median":10.012625,"eighty":11.396882,"marketCap":193689705547.03},{"date":"2022-12-23","current":9.92954,"twenty":8.498306,"median":10.009884,"eighty":11.396882,"marketCap":186680586153.25},{"date":"2022-12-30","current":9.8995,"twenty":8.498306,"median":10.004188,"eighty":11.396882,"marketCap":187424120297.56},{"date":"2023-01-06","current":9.967773,"twenty":8.498306,"median":10.002518,"eighty":11.396882,"marketCap":187826513885.49},{"date":"2023-01-13","current":9.900927,"twenty":8.498306,"median":9.99775,"eighty":11.391839,"marketCap":193695001985.49},{"date":"2023-01-20","current":10.269042,"twenty":8.498306,"median":9.99775,"eighty":11.371547,"marketCap":197429750273.07},{"date":"2023-01-27","current":10.364479,"twenty":8.498306,"median":9.99775,"eighty":11.356276,"marketCap":199180241789.68},{"date":"2023-02-03","current":10.30012,"twenty":8.498306,"median":9.99775,"eighty":11.333641,"marketCap":196422447417.63},{"date":"2023-02-10","current":10.500354,"twenty":8.498306,"median":10.002518,"eighty":11.333641,"marketCap":194355374375.32},{"date":"2023-02-17","current":10.65962,"twenty":8.498306,"median":10.008162,"eighty":11.333641,"marketCap":192970903798.5},{"date":"2023-02-24","current":10.383001,"twenty":8.498306,"median":10.012625,"eighty":11.333641,"marketCap":185357918633.29},{"date":"2023-03-03","current":10.517526,"twenty":8.510764,"median":10.0275,"eighty":11.333641,"marketCap":187828381133.47},{"date":"2023-03-10","current":10.581708,"twenty":8.548174,"median":10.042435,"eighty":11.333641,"marketCap":190727411760.14},{"date":"2023-03-17","current":9.967791,"twenty":8.592191,"median":10.055161,"eighty":11.333641,"marketCap":183499755175.24},{"date":"2023-03-24","current":9.947037,"twenty":8.631375,"median":10.055161,"eighty":11.333641,"marketCap":185142028497.28},{"date":"2023-03-31","current":10.482303,"twenty":8.645153,"median":10.059123,"eighty":11.328108,"marketCap":191843639012.74},{"date":"2023-04-06","current":10.184004,"twenty":8.648723,"median":10.066202,"eighty":11.328108,"marketCap":188162070105.05},{"date":"2023-04-14","current":10.080853,"twenty":8.66463,"median":10.076589,"eighty":11.333641,"marketCap":185220967562.58},{"date":"2023-04-21","current":10.047399,"twenty":8.673795,"median":10.082108,"eighty":11.333641,"marketCap":182347845691.72},{"date":"2023-04-28","current":10.354062,"twenty":8.687916,"median":10.087954,"eighty":11.333641,"marketCap":188050875815.22},{"date":"2023-05-05","current":10.39588,"twenty":8.698992,"median":10.096155,"eighty":11.333641,"marketCap":188685008663.47},{"date":"2023-05-12","current":10.7467,"twenty":8.71352,"median":10.103167,"eighty":11.339175,"marketCap":196024816270.07},{"date":"2023-05-19","current":10.843542,"twenty":8.712564,"median":10.107669,"eighty":11.350241,"marketCap":191831714435.03},{"date":"2023-05-24","current":10.826941,"twenty":8.714955,"median":10.11015,"eighty":11.350241,"marketCap":190788985103.57},{"date":"2023-06-09","current":11.342728,"twenty":8.766683,"median":10.124788,"eighty":11.356641,"marketCap":200031894537.04},{"date":"2023-06-16","current":12.805147,"twenty":8.799234,"median":10.137578,"eighty":11.391839,"marketCap":223365019400.58},{"date":"2023-06-23","current":12.161019,"twenty":8.828227,"median":10.143938,"eighty":11.422196,"marketCap":208670959088.58},{"date":"2023-06-29","current":12.691802,"twenty":8.864323,"median":10.150966,"eighty":11.489152,"marketCap":215086680971.05},{"date":"2023-07-03","current":12.857672,"twenty":8.872176,"median":10.160675,"eighty":11.502548,"marketCap":218018238631.84},{"date":"2023-07-12","current":12.147683,"twenty":8.918218,"median":10.163979,"eighty":11.779334,"marketCap":215254189834.62},{"date":"2023-07-20","current":12.639559,"twenty":8.96426,"median":10.167277,"eighty":11.966324,"marketCap":220786122927.06},{"date":"2023-07-28","current":12.766673,"twenty":9.010002,"median":10.174767,"eighty":12.00188,"marketCap":221871351348.02},{"date":"2023-08-04","current":10.899958,"twenty":9.031492,"median":10.17782,"eighty":12.007361,"marketCap":231851878614.13},{"date":"2023-08-11","current":10.861948,"twenty":9.04236,"median":10.184004,"eighty":12.007361,"marketCap":227593958068.73},{"date":"2023-08-18","current":10.504206,"twenty":9.078146,"median":10.189579,"eighty":12.007361,"marketCap":217607210721.31},{"date":"2023-08-25","current":10.709908,"twenty":9.10278,"median":10.197801,"eighty":12.007361,"marketCap":222436604173.45},{"date":"2023-09-01","current":11.266644,"twenty":9.122869,"median":10.217604,"eighty":12.007361,"marketCap":234091178799.61},{"date":"2023-09-08","current":11.632383,"twenty":9.129306,"median":10.223034,"eighty":12.007361,"marketCap":239062167551.94},{"date":"2023-09-15","current":12.608824,"twenty":9.149677,"median":10.231608,"eighty":12.038468,"marketCap":259256210611.1},{"date":"2023-09-22","current":12.461352,"twenty":9.160246,"median":10.253921,"eighty":12.102922,"marketCap":255740860659.18},{"date":"2023-09-29","current":11.965312,"twenty":9.176462,"median":10.263466,"eighty":12.122846,"marketCap":242410597101.79},{"date":"2023-10-05","current":11.567214,"twenty":9.18527,"median":10.271329,"eighty":12.123833,"marketCap":235551857382.08},{"date":"2023-10-12","current":12.23713,"twenty":9.197232,"median":10.271457,"eighty":12.139596,"marketCap":247225582426.59},{"date":"2023-10-20","current":11.687799,"twenty":9.211776,"median":10.276468,"eighty":12.142831,"marketCap":235929020292.45},{"date":"2023-11-03","current":9.638628,"twenty":9.235475,"median":10.293128,"eighty":12.148482,"marketCap":247832080640.27},{"date":"2023-11-10","current":9.779528,"twenty":9.258366,"median":10.293128,"eighty":12.148482,"marketCap":250599077838.42},{"date":"2023-11-17","current":10.091789,"twenty":9.275495,"median":10.293128,"eighty":12.148482,"marketCap":259396028596.42},{"date":"2023-11-24","current":9.779528,"twenty":9.28243,"median":10.293128,"eighty":12.148482,"marketCap":252923781896.85},{"date":"2023-12-01","current":9.884197,"twenty":9.289465,"median":10.293128,"eighty":12.148482,"marketCap":258764509700.73},{"date":"2023-12-08","current":9.347202,"twenty":9.298314,"median":10.288648,"eighty":12.148216,"marketCap":250910555795.92},{"date":"2023-12-15","current":9.068233,"twenty":9.30405,"median":10.293128,"eighty":12.148482,"marketCap":247803779364.67},{"date":"2023-12-21","current":8.848545,"twenty":9.30405,"median":10.293128,"eighty":12.148482,"marketCap":238192449604.09},{"date":"2023-12-29","current":9.033362,"twenty":9.307273,"median":10.297791,"eighty":12.149015,"marketCap":247750139359.73},{"date":"2024-01-05","current":9.420431,"twenty":9.308671,"median":10.297973,"eighty":12.150743,"marketCap":252256823254.4},{"date":"2024-01-12","current":9.887005,"twenty":9.327923,"median":10.297973,"eighty":12.150743,"marketCap":261924877051.17},{"date":"2024-01-19","current":10.322632,"twenty":9.349294,"median":10.300942,"eighty":12.152471,"marketCap":269866492565.03},{"date":"2024-01-26","current":10.080423,"twenty":9.369845,"median":10.312289,"eighty":12.150743,"marketCap":264286074026.99},{"date":"2024-02-02","current":10.28604,"twenty":9.388706,"median":10.31924,"eighty":12.150743,"marketCap":272255603890.7},{"date":"2024-02-09","current":9.957996,"twenty":9.394266,"median":10.32256,"eighty":12.150743,"marketCap":299960785015.74},{"date":"2024-02-16","current":10.230695,"twenty":9.394266,"median":10.32256,"eighty":12.150743,"marketCap":306411060067.22},{"date":"2024-02-23","current":10.551341,"twenty":9.394266,"median":10.323577,"eighty":12.150743,"marketCap":315378380929.65},{"date":"2024-03-01","current":11.027814,"twenty":9.394278,"median":10.33109,"eighty":12.149015,"marketCap":331146760105.98},{"date":"2024-03-08","current":10.813788,"twenty":9.394278,"median":10.335285,"eighty":12.149015,"marketCap":328807996181.04},{"date":"2024-03-15","current":10.448336,"twenty":9.394278,"median":10.34246,"eighty":12.149015,"marketCap":317352794924.37},{"date":"2024-03-22","current":11.598612,"twenty":9.394278,"median":10.355684,"eighty":12.149015,"marketCap":344082353343.51},{"date":"2024-03-28","current":11.400908,"twenty":9.394278,"median":10.3593,"eighty":12.149015,"marketCap":339062320000.54},{"date":"2024-04-05","current":10.837354,"twenty":9.394266,"median":10.37261,"eighty":12.150743,"marketCap":321490532674.96},{"date":"2024-04-12","current":11.28055,"twenty":9.394266,"median":10.377412,"eighty":12.150743,"marketCap":331086520232.15},{"date":"2024-04-19","current":10.54688,"twenty":9.394266,"median":10.38364,"eighty":12.150743,"marketCap":306968136269.85},{"date":"2024-04-26","current":10.510945,"twenty":9.394278,"median":10.389205,"eighty":12.149015,"marketCap":304094877924.26},{"date":"2024-05-03","current":10.72356,"twenty":9.394278,"median":10.39588,"eighty":12.149015,"marketCap":313701286943.33},{"date":"2024-05-10","current":8.968812,"twenty":9.394219,"median":10.405631,"eighty":12.149015,"marketCap":284988352069.93},{"date":"2024-05-17","current":9.35894,"twenty":9.370205,"median":10.405631,"eighty":12.149015,"marketCap":298070569595.92},{"date":"2024-05-24","current":9.241817,"twenty":9.361646,"median":10.405631,"eighty":12.149015,"marketCap":290894869344.83},{"date":"2024-05-31","current":9.263607,"twenty":9.350689,"median":10.405631,"eighty":12.149015,"marketCap":292373544175.41},{"date":"2024-06-07","current":8.767878,"twenty":9.330368,"median":10.405631,"eighty":12.149015,"marketCap":277873277699.88},{"date":"2024-06-14","current":8.487327,"twenty":9.308671,"median":10.405631,"eighty":12.149015,"marketCap":267473488691.17},{"date":"2024-06-21","current":8.372928,"twenty":9.301945,"median":10.408148,"eighty":12.150743,"marketCap":260910138589.3},{"date":"2024-06-28","current":8.961267,"twenty":9.298847,"median":10.412275,"eighty":12.157656,"marketCap":275771302935.71},{"date":"2024-07-05","current":9.040257,"twenty":9.291914,"median":10.412275,"eighty":12.157656,"marketCap":277390762189.75},{"date":"2024-07-12","current":8.917686,"twenty":9.282674,"median":10.412275,"eighty":12.157656,"marketCap":278137816190.97},{"date":"2024-07-15","current":8.917686,"twenty":9.28243,"median":10.412275,"eighty":12.157656,"marketCap":279355354112.01},{"date":"2024-08-02","current":7.041317,"twenty":9.276817,"median":10.39588,"eighty":12.184402,"marketCap":231924591714.35},{"date":"2024-08-09","current":6.637283,"twenty":9.265654,"median":10.39588,"eighty":12.184402,"marketCap":223881488426.31},{"date":"2024-08-16","current":7.442706,"twenty":9.252106,"median":10.39588,"eighty":12.184402,"marketCap":248253869142.74},{"date":"2024-08-23","current":7.273214,"twenty":9.233928,"median":10.39588,"eighty":12.184402,"marketCap":247232647793.85},{"date":"2024-08-30","current":7.483383,"twenty":9.22424,"median":10.39588,"eighty":12.184402,"marketCap":255852831018.33},{"date":"2024-09-06","current":7.003384,"twenty":9.219097,"median":10.39588,"eighty":12.184402,"marketCap":242110054996.92},{"date":"2024-09-13","current":6.657621,"twenty":9.20585,"median":10.390862,"eighty":12.184402,"marketCap":232274731105.64},{"date":"2024-09-20","current":7.143045,"twenty":9.191896,"median":10.382809,"eighty":12.184402,"marketCap":248538318454.32},{"date":"2024-09-27","current":7.44525,"twenty":9.18363,"median":10.373181,"eighty":12.184402,"marketCap":255458190614.14},{"date":"2024-10-04","current":6.997426,"twenty":9.168808,"median":10.358804,"eighty":12.184402,"marketCap":236830385239.74},{"date":"2024-10-11","current":6.932484,"twenty":9.1553,"median":10.354854,"eighty":12.184402,"marketCap":231904929554.32},{"date":"2024-10-18","current":6.757684,"twenty":9.141533,"median":10.335285,"eighty":12.184402,"marketCap":223778731168.75},{"date":"2024-10-25","current":6.883439,"twenty":9.129284,"median":10.329287,"eighty":12.184402,"marketCap":225048774919.69},{"date":"2024-10-31","current":7.101856,"twenty":9.122712,"median":10.322596,"eighty":12.184402,"marketCap":231437178743.57},{"date":"2024-11-08","current":8.200075,"twenty":9.102264,"median":10.31392,"eighty":12.18547,"marketCap":228195126660.03},{"date":"2024-11-15","current":8.327889,"twenty":9.082145,"median":10.30012,"eighty":12.18547,"marketCap":227851679690.47},{"date":"2024-11-22","current":8.206235,"twenty":9.064377,"median":10.276611,"eighty":12.18547,"marketCap":226334810049.29},{"date":"2024-11-29","current":7.858213,"twenty":9.045208,"median":10.270427,"eighty":12.18547,"marketCap":221081895555.64},{"date":"2024-12-06","current":8.096901,"twenty":9.033515,"median":10.254464,"eighty":12.18547,"marketCap":229868025198.21},{"date":"2024-12-13","current":8.30787,"twenty":9.021772,"median":10.22796,"eighty":12.18547,"marketCap":232643820156.81},{"date":"2024-12-20","current":8.535778,"twenty":9.007394,"median":10.218161,"eighty":12.18547,"marketCap":230746247381.81},{"date":"2024-12-27","current":9.818531,"twenty":8.9986,"median":10.200346,"eighty":12.18547,"marketCap":264870066494.9},{"date":"2025-01-03","current":9.675442,"twenty":8.9986,"median":10.189579,"eighty":12.18547,"marketCap":261830247114.05},{"date":"2025-01-10","current":9.007894,"twenty":8.9986,"median":10.180013,"eighty":12.186538,"marketCap":243092635183.17},{"date":"2025-01-17","current":8.565487,"twenty":8.967107,"median":10.171523,"eighty":12.186538,"marketCap":235114492848.26},{"date":"2025-01-24","current":8.855817,"twenty":8.961267,"median":10.165658,"eighty":12.186538,"marketCap":242008458741.27},{"date":"2025-01-31","current":9.135393,"twenty":8.957202,"median":10.141395,"eighty":12.186538,"marketCap":252298057008.53},{"date":"2025-02-07","current":7.246926,"twenty":8.947648,"median":10.131987,"eighty":12.186538,"marketCap":243295591170.03},{"date":"2025-02-14","current":7.195611,"twenty":8.947648,"median":10.131987,"eighty":12.186538,"marketCap":239862178438.66},{"date":"2025-02-21","current":6.942886,"twenty":8.947648,"median":10.131987,"eighty":12.186538,"marketCap":236481636207.77},{"date":"2025-02-28","current":6.899269,"twenty":8.947648,"median":10.131987,"eighty":12.186538,"marketCap":234522781422.4},{"date":"2025-03-07","current":7.181905,"twenty":8.952256,"median":10.133998,"eighty":12.187463,"marketCap":247050876999.6},{"date":"2025-03-14","current":7.03714,"twenty":8.952256,"median":10.133998,"eighty":12.187463,"marketCap":242985940371.29},{"date":"2025-03-21","current":7.288238,"twenty":8.952256,"median":10.133998,"eighty":12.187463,"marketCap":249726240097.54},{"date":"2025-03-28","current":6.919278,"twenty":8.952256,"median":10.133998,"eighty":12.187463,"marketCap":233662092178.64},{"date":"2025-04-04","current":6.162183,"twenty":8.952256,"median":10.133998,"eighty":12.187463,"marketCap":215308987506.32},{"date":"2025-04-11","current":6.194178,"twenty":8.947648,"median":10.131987,"eighty":12.186538,"marketCap":218785571059.41},{"date":"2025-04-17","current":6.395105,"twenty":8.947648,"median":10.131987,"eighty":12.186538,"marketCap":229351374300.22},{"date":"2025-04-25","current":6.885264,"twenty":8.952256,"median":10.133998,"eighty":12.187463,"marketCap":246031968895.36},{"date":"2025-05-02","current":7.106778,"twenty":8.952256,"median":10.133998,"eighty":12.187463,"marketCap":249213599815.24},{"date":"2025-05-09","current":7.437943,"twenty":8.952256,"median":10.133998,"eighty":12.187463,"marketCap":244240265458.25},{"date":"2025-05-16","current":7.227345,"twenty":8.952256,"median":10.133998,"eighty":12.187463,"marketCap":236183901810.15},{"date":"2025-05-23","current":7.175379,"twenty":8.952256,"median":10.133998,"eighty":12.187463,"marketCap":237806187933.75},{"date":"2025-05-30","current":7.573327,"twenty":8.942194,"median":10.133998,"eighty":12.187463,"marketCap":250196249736.93},{"date":"2025-06-06","current":7.253328,"twenty":8.917141,"median":10.133998,"eighty":12.187463,"marketCap":240568591737.01},{"date":"2025-06-13","current":6.988029,"twenty":8.896562,"median":10.133998,"eighty":12.187463,"marketCap":231679210496.78},{"date":"2025-06-20","current":6.844439,"twenty":8.874332,"median":10.13429,"eighty":12.188387,"marketCap":223775204425.4},{"date":"2025-06-27","current":6.911447,"twenty":8.854761,"median":10.13429,"eighty":12.188387,"marketCap":227922345870.74},{"date":"2025-07-03","current":6.869054,"twenty":8.832895,"median":10.13429,"eighty":12.188387,"marketCap":225981638453.82},{"date":"2025-07-11","current":6.859481,"twenty":8.818202,"median":10.13429,"eighty":12.188387,"marketCap":223205689863.85},{"date":"2025-07-18","current":6.881362,"twenty":8.755943,"median":10.13429,"eighty":12.188387,"marketCap":220798069049.78},{"date":"2025-07-25","current":7.622558,"twenty":8.72522,"median":10.13429,"eighty":12.188387,"marketCap":247481668440},{"date":"2025-08-01","current":7.451617,"twenty":8.675821,"median":10.13429,"eighty":12.188387,"marketCap":235893267000.58},{"date":"2025-08-08","current":8.457965,"twenty":8.591357,"median":10.129531,"eighty":12.169091,"marketCap":245167376130.22},{"date":"2025-08-15","current":8.705024,"twenty":8.549275,"median":10.11015,"eighty":12.131916,"marketCap":251818018551.78},{"date":"2025-08-22","current":8.976484,"twenty":8.549275,"median":10.097345,"eighty":12.100682,"marketCap":258887369440.83},{"date":"2025-08-29","current":8.762976,"twenty":8.549275,"median":10.086949,"eighty":12.029251,"marketCap":254691051237.66},{"date":"2025-09-05","current":9.035961,"twenty":8.546128,"median":10.073721,"eighty":11.996899,"marketCap":259717499918.27},{"date":"2025-09-12","current":8.811778,"twenty":8.549275,"median":10.058874,"eighty":11.962956,"marketCap":255832771462.94},{"date":"2025-09-19","current":8.915482,"twenty":8.549275,"median":10.046043,"eighty":11.826465,"marketCap":257529541517.41},{"date":"2025-09-26","current":9.057312,"twenty":8.549275,"median":10.036139,"eighty":11.659912,"marketCap":258443271914.81},{"date":"2025-10-03","current":8.660797,"twenty":8.549275,"median":10.023168,"eighty":11.568256,"marketCap":251082563433.89},{"date":"2025-10-10","current":8.840754,"twenty":8.549275,"median":10.003584,"eighty":11.452811,"marketCap":246650808761.59},{"date":"2025-10-17","current":8.947508,"twenty":8.549275,"median":9.979594,"eighty":11.337752,"marketCap":253592982643.91},{"date":"2025-10-24","current":9.537705,"twenty":8.549275,"median":9.967773,"eighty":11.28055,"marketCap":266870625343.7},{"date":"2025-10-31","current":9.571256,"twenty":8.549275,"median":9.958289,"eighty":11.209109,"marketCap":265411053652.74},{"date":"2025-11-07","current":8.774478,"twenty":8.549275,"median":9.945195,"eighty":11.180772,"marketCap":265409055839.35},{"date":"2025-11-14","current":8.948954,"twenty":8.549275,"median":9.929547,"eighty":11.080493,"marketCap":268538147702.6},{"date":"2025-11-21","current":8.715381,"twenty":8.538212,"median":9.925171,"eighty":11.0091,"marketCap":256286827122.06},{"date":"2025-11-28","current":8.81669,"twenty":8.538212,"median":9.90985,"eighty":10.993116,"marketCap":261289943005.86},{"date":"2025-12-05","current":8.532462,"twenty":8.530036,"median":9.8995,"eighty":10.967688,"marketCap":255346933696.96},{"date":"2025-12-12","current":9.174085,"twenty":8.530036,"median":9.882026,"eighty":10.944626,"marketCap":273667846563.7},{"date":"2025-12-19","current":9.635604,"twenty":8.530036,"median":9.877292,"eighty":10.923873,"marketCap":287107870130.45},{"date":"2025-12-26","current":9.511782,"twenty":8.530036,"median":9.865354,"eighty":10.903594,"marketCap":282368379100.45},{"date":"2026-01-02","current":9.444242,"twenty":8.530036,"median":9.850316,"eighty":10.894285,"marketCap":279079016263.41},{"date":"2026-01-09","current":9.534295,"twenty":8.530036,"median":9.842475,"eighty":10.876951,"marketCap":281377428911.71},{"date":"2026-01-16","current":10.327881,"twenty":8.530036,"median":9.835746,"eighty":10.857459,"marketCap":301858755734.76},{"date":"2026-01-23","current":10.198431,"twenty":8.530036,"median":9.835746,"eighty":10.845279,"marketCap":298327517461.79},{"date":"2026-01-30","current":9.860734,"twenty":8.530036,"median":9.821374,"eighty":10.833289,"marketCap":298603364827.03},{"date":"2026-02-06","current":10.637434,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":313859436118.34},{"date":"2026-02-13","current":13.309926,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":322679691855.59},{"date":"2026-02-20","current":12.819708,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":305795987508.04},{"date":"2026-02-27","current":13.48979,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":319159438097.15},{"date":"2026-03-06","current":12.396499,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":290370625620.55},{"date":"2026-03-13","current":11.885122,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":275846668111.07},{"date":"2026-03-20","current":11.726418,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":274144947508.33},{"date":"2026-03-27","current":12.019138,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":278207544709.07},{"date":"2026-04-02","current":11.504234,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":266895849834.11},{"date":"2026-04-10","current":11.705258,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":271784788749.28},{"date":"2026-04-17","current":11.7899,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":273739770735.08},{"date":"2026-04-24","current":10.816519,"twenty":8.530036,"median":9.821374,"eighty":10.80613,"marketCap":250804029913.91},{"date":"2026-05-01","current":10.58067,"twenty":8.530036,"median":9.821374,"eighty":10.804477,"marketCap":249475525227.13},{"date":"2026-05-08","current":10.27383,"twenty":8.530036,"median":9.821374,"eighty":10.789706,"marketCap":242686668031.95},{"date":"2026-05-15","current":10.448796,"twenty":8.530036,"median":9.813058,"eighty":10.78211,"marketCap":254250843238.65},{"date":"2026-05-22","current":10.116873,"twenty":8.530036,"median":9.813058,"eighty":10.770839,"marketCap":244551983917.77},{"date":"2026-05-29","current":10.303156,"twenty":8.528822,"median":9.810851,"eighty":10.746414,"marketCap":249026792097.91},{"date":"2026-06-05","current":9.652859,"twenty":8.530036,"median":9.790714,"eighty":10.730763,"marketCap":232162965017.25},{"date":"2026-06-12","current":9.400529,"twenty":8.530036,"median":9.776577,"eighty":10.722324,"marketCap":225409445343.32},{"date":"2026-06-18","current":9.461495,"twenty":8.530036,"median":9.756873,"eighty":10.712432,"marketCap":226168054168.62},{"date":"2026-06-26","current":8.517464,"twenty":8.518484,"median":9.744733,"eighty":10.694148,"marketCap":202764288143.33},{"date":"2026-07-02","current":8.594392,"twenty":8.46971,"median":9.720598,"eighty":10.684972,"marketCap":205548036688.17},{"date":"2026-07-10","current":8.686706,"twenty":8.46971,"median":9.699282,"eighty":10.660921,"marketCap":205879997686.52},{"date":"2026-07-17","current":8.922105,"twenty":8.46971,"median":9.675442,"eighty":10.645845,"marketCap":211339353408.91},{"date":"2026-07-24","current":8.914412,"twenty":8.46971,"median":9.660114,"eighty":10.632603,"marketCap":209329981292},{"date":"2026-07-31","current":9.437522,"twenty":8.463837,"median":9.648212,"eighty":10.617627,"marketCap":227758266571.16},{"date":"2026-08-07","current":7.870264,"twenty":8.402034,"median":9.643002,"eighty":10.611709,"marketCap":222762283048.22},{"date":"2026-08-14","current":7.975905,"twenty":8.375064,"median":9.643002,"eighty":10.611709,"marketCap":224396770135.09},{"date":"2026-08-21","current":8.2717,"twenty":8.315982,"median":9.643002,"eighty":10.611709,"marketCap":233618820103.18}],"updateTime":1787457123058},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TM\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659129230","title":"Press Release: Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659129230","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659129230?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:30","pubTimestamp":1786739400,"startTime":"0","endTime":"0","summary":"$7.1 million in revenue for the first nine months of fiscal 2026 as the LYMPHIR(R) launch progressesStrong institutional demand drives growth in total vials ordered and number of institutions ordering","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DT","LU1169589451.USD","BK4022","BK4232","BK4139","BK4213","CTOR","BK4007","BK4555","CTXR","BK4023","LU1169590202.USD","TM","ORR","PXI","LU0348723411.USD","FXN","BK4585","BK4588","BK4560","BK4161","BK4099","03160","CR","PR","BK4604","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659412930","title":"Press Release: Cerenome Reports Second Quarter 2026 Financial Results and Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659412930","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659412930?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:15","pubTimestamp":1786738500,"startTime":"0","endTime":"0","summary":"August 3, 2026, with the Company's common stock trading on the Nasdaq. Capital Market under the ticker symbol \"CNSY\"REYOBIQ Development-- Continued enrollment in the ReSPECT-LM multiple-dose clinical trial. As. of June 30, 2026, approximately one-third of patients had been enrolled,with no dose-limiting toxicities observed to date, supporting the. development of a recommended Phase 2 dose/dosing regimen by year-end. -- Continued enrollment in the ReSPECT-GBM Phase 2 trial. Current enrollment. rates indicate full enrollment in 2026 followed by a data readout and a. subsequent End-of-Phase 2 meeting with the U.S. Food and Drug. -- Initial site activation of the ReSPECT-PBC pediatric brain cancer Phase 1. trial at Lurie Children's Hospital. First dosing expected in the third. -- Continued commercial-level manufacturing scale-up and supply chain. enhancement for REYOBIQ drug supplyCNSide CSF Assay Platform-- Performed 232 CNSide cerebrospinal fluid tests during the first half of. 2026 and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4555","BK4022","R","BK4604","03160","BK4202","CNSY","LCLG","NCI","TM","BK4585","BK4099","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659126775","title":"Press Release: Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2659126775","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659126775?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:05","pubTimestamp":1786737900,"startTime":"0","endTime":"0","summary":"EB-003 Development Highlights:--  Continued advancing IND-enabling studies supporting the planned. submission of an Investigational New Drug  application for EB-003. --  Reported preclinical data demonstrating that EB-003 consistently. exhibited a non-hallucinogenic profile in a highly sensitive. --  Announced promising results from preclinical in vitro experiments. indicating no photoreactive potential for EB-003, further derisking its. continued development as a potential treatment of neuropsychiatric. --  Initiated genotoxicity studies to evaluate the potential for EB-003 to. interact with DNA and cause genetic mutations, a critical measure of. --  Secured U.S. Patent No. 12,605,361 pertaining to the Company's EVM301. Series of molecules being developed as potential treatments for mental","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","03160","ENVB","MEDX","NVIB","BK4604","IND","BK4099","TM","BK4588","GDOC","BK4007","IDNA","HYLG","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659144159","title":"Press Release: Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2659144159","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659144159?lang=en_us&edition=fundamental","pubTime":"2026-08-14 21:15","pubTimestamp":1786713300,"startTime":"0","endTime":"0","summary":"compared to the second quarter of 2025, marking the strongest quarterly. revenue performance since the fourth quarter of 2024. The increase. reflects continued execution of Lifeward's commercial strategy and. -- Strengthened the Company's balance sheet to a proforma cash balance of. approximately $11 million. The Company had a cash balance of $9.4 million. as of June 30, 2026. Through a strategic financing closed on July 6,2026, providing up to $11.2 million in growth capital, Lifeward raised. approximately $5.6 million, $4.1 million of which was received during the. second quarter, and $1.5 million was received in July. An additional. approximately $5.6 million is available upon achieving either a 150%. increase in ReWalk sales or the Company's common stock trading at $13.80. rehabilitation and durable medical equipment distribution partners while. building scalable commercial infrastructure designed to support portfolio. Care, a leading U.S. mobility technology patient care organizat","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","BK4082","BK4022","03160","BK4588","LFWD","R","BK4555","BK4604","TM","BK4232","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659314135","title":"Press Release: Quoin Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659314135","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659314135?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:30","pubTimestamp":1786710600,"startTime":"0","endTime":"0","summary":"-- Receives FDA Conditional Approval of QYLEKI(TM) as the Proposed Brand Name for QRX003 for Netherton Syndrome-- Reports Positive Clinical Update from Ongoing Pediatric Compassionate Use Program in N","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","BK4588","TM","BK4555","BK4604","QNRX","03160","BK4139","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659203146","title":"Press Release: Evaxion to Announce Business Update and Second Quarter 2026 Financial Results on August 20, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2659203146","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659203146?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:00","pubTimestamp":1786708800,"startTime":"0","endTime":"0","summary":"COPENHAGEN, Denmark, August 14, 2026 - Evaxion A/S (NASDAQ: EVAX) (\"Evaxion\"), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology(TM) platform, will provide a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIPO","ARTY","QTOC","EVAX","BK4555","BK4099","03160","BK4139","BK4588","BK4585","VTHR","BK4604","AGIX","CHAT","TM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659450691","title":"Press Release: Lantern Pharma Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659450691","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659450691?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:30","pubTimestamp":1786707000,"startTime":"0","endTime":"0","summary":"Open Medicine AI Established as a Separate Company with Executed Commercial Licenses; Progression-Free Survival Benefit Deepens in EGFR Exon 21 L858R Lung Cancer with LP-300; EMA Clears LP-184, zirdafulven, for Biomarker-Selected Bladder Cancer Trial; LP-184 Development Positioned to Advance in Multiple Indications including Triple Negative Breast Cancer and Pediatric Brain Cancers--  Open Medicine AI  established as a separate company with. withZeta.ai. OMAI is currently wholly owned by Lantern and intends to. raise capital at the OMAI level. A dedicated OMAI informational call is. planned for mid-September 2026 to detail the market opportunity, platform. --  LP-300 -- HARMONIC benefit deepens with treatment duration in. emerging dataset: Median progression-free survival of 8.9 months in EGFR. exon 21 L858R patients who completed six cycles of LP-300 (n=9), compared. with 8.4 months across the overall L858R cohort , and a hazard. clinical benefit rate and tumor reduction in more than ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIX","BK4099","BK4081","03160","BK4232","BK4604","ARTY","R","BK4585","BK4139","EMA","AIPO","BK4588","BK4022","TM","CHAT","VGT","LTRN","BK4555","QTOC","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659145061","title":"Press Release: Milestone Scientific Reports Financial Results for Second Quarter 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2659145061","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659145061?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:30","pubTimestamp":1786707000,"startTime":"0","endTime":"0","summary":"Medical Segment Revenue Grows 231% Year-Over-YearEnters Strategic Distribution Agreement to Expand CompuFlo(R) Access Across VA and Department of Defense Health SystemsReaffirms 2026 Outlook for Doubl","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASPN","BK4109","IE00B19Z4B17.USD","R","IE00B7SZL793.SGD","BK4604","BK4585","03160","BK4555","TM","BK4588","MLSS","BK4232","BK4099","IE00B66KJ199.SGD","BK4082","BK4022","IE0031619046.USD","BK4179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659145220","title":"Press Release: Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2659145220","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659145220?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:28","pubTimestamp":1786706880,"startTime":"0","endTime":"0","summary":"- Appointed Michael Halstead, former President of Intra-Cellular Therapies, as Chief Executive Officer to lead Helus Pharma through late-stage development and commercialization -- Completed enrollment","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","BK4585","TM","BK4099","BK4604","03160","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659145631","title":"Press Release: Payward Reports Second Quarter 2026 Adjusted Revenue of $508 Million, up 17% Year over Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2659145631","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659145631?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:14","pubTimestamp":1786706040,"startTime":"0","endTime":"0","summary":"Funded accounts grew 42% to 6.6 million; asset-based and other revenue. reached 60% of total revenue as growth broadened beyond trading. Payward, Inc., the unified financial infrastructure platform behind a. family of products including Kraken, today reported financial results. for the second quarter ended June 30, 2026.year, and remained Adjusted EBITDA positive at $23 million. Growth was. broad-based across the company's four business pillars. As crypto spot. volumes declined across the industry,[1] Payward's traditional futures,equities and tokenized equities activity grew, and the company gained. spot market share for the third consecutive quarter.\"Three forces are rearranging global markets: convergence across asset. classes, the onshoring of activity into regulated venues, and the. automation of market participation,\" said Arjun Sethi, Co-CEO of. Payward. \"Each rewards the same decision we made years ago -- to build. one platform rather than a collection of products. One matching","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BITW","CRPT","BK4588","GDLC","STCE","BK4099","APT.USD.CC","DAPP","TON.USD.CC","BK4604","TEKX","TM","BKCH","DIME","03160","BITQ","NCIQ","LFGY","APT.USD.HKCC","BK4555","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659145865","title":"Press Release: Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2659145865","media":"Dow Jones","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659145865?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:00","pubTimestamp":1786705200,"startTime":"0","endTime":"0","summary":"US$9.5 million as of June 30, 2026, increased from US$4.1 million as of. -- Cash and cash equivalents nearly doubled to US$3.65 million, up from. -- Total shareholders' equity increased to US$6.09 million, up approximately. 19% from US$5.10 million at December 31, 2025, reflecting a strengthened. -- Working capital improved significantly to approximately US$1.66 million. as of June 30, 2026, up from approximately US$0.42 million at December. 31, 2025, indicating strengthened short-term liquidity and full coverage. -- Quick ratio of 1.19 as of June 30, 2026, compared to 1.06 as of December. divided by current liabilities), confirming robust liquidity even on a. December 31, 2025. Importantly, approximately 47% of current liabilities,items, reflecting the Company's strong balance sheet management.Reduced Cash Burn and Cost Discipline-- Total operating expenses decreased by 53% in the second quarter of 2026. compared to the same period in 2025, to US$2.29 million from US$4.85. -- General ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IAI","IE00B775SV38.USD","03160","LU0795875169.SGD","LU1548497426.USD","NVIB","LU0053666078.USD","LU0106831901.USD","LU1244550494.USD","LU1244550221.USD","BK4099","BK4596","LU0006306889.USD","LU2133065610.SGD","EQR","LU0912757837.SGD","QNTM","LU2023251221.USD","LU1791710582.SGD","LU1732800096.USD","LU0210528500.USD","LU0314104364.USD","REZ","LCID","LU0267386448.USD","LU2089283258.USD","BK4551","LU1988902786.USD","LU2264538146.SGD","LU0234570918.USD","LU0098860793.USD","LU1732799900.SGD","VMRK","LU0106261372.USD","TM","KBWB","BK4585","LABU","BK4516","LU2111349929.HKD","LCDL","LU1244550577.SGD","LU1989772923.USD","BK4581","IND","LU0158827948.USD","LU0390134368.USD","LU2357305700.SGD","LCIZ","BK4127","LU1791710400.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659419622","title":"Press Release: BTQ Technologies Announces 2026 AGM Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659419622","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659419622?lang=en_us&edition=fundamental","pubTime":"2026-08-14 08:32","pubTimestamp":1786667520,"startTime":"0","endTime":"0","summary":"VANCOUVER, BC, Aug. 13, 2026 /PRNewswire/ -- BTQ Technologies Corp.   , a global technology company building the trust infrastructure for the quantum era, is pleased to provide the voting results from the 2026 Annual Meeting of shareholders. The Company announces that the nominees listed in the management proxy circular dated June 29, 2026  for the 2026 annual meeting of shareholders of the Company  were elected as directors of the Company.Detailed results of the vote for the election of directors held at the Meeting on August 12, 2026 in Vancouver, British Columbia are set out below.Fixing Number of Directors at five The number of directors of the Company was fixed at five . The results of the votes cast are set out below:Votes For      % For     Votes Against    % Against. 47,773,250    92.32 %      3,973,272       7.68 %No other business was voted upon at the Meeting.A total of 70,852,597 common shares were voted in connection with the Meeting, representing approximately 49.97% of t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTUP","03160","BK4099","BK4588","TM","BK4604","BTQ","BK4097","BK4555","QPUX","AGM","BK4127","BK4229","BK4195","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659216764","title":"Press Release: Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2659216764","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659216764?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:20","pubTimestamp":1786652400,"startTime":"0","endTime":"0","summary":"open-label Phase 3 registrational trial being conducted at sites across. the United States, with topline data anticipated in the second half of. -- The trial is evaluating Olvi-Vec followed by platinum-doublet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLTM","TM","BK4604","03160","BK4555","BK4585","BK4588","BK4139","BK4099","GNLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659673211","title":"Press Release: Tri Pointe Homes, Inc. Reports 2026 Second Quarter Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659673211","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659673211?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:15","pubTimestamp":1786652100,"startTime":"0","endTime":"0","summary":"INCLINE VILLAGE, Nev., Aug. 13, 2026  -- Tri Pointe Homes, Inc.  today announced results for the second quarter ended June 30, 2026.Results and Operational Data for Second Quarter 2026 and Comparisons to Second Quarter 2025-- Home sales revenue of $685.1 million compared to $879.8 million. -- New home deliveries of 1,013 homes compared to 1,326 homes. -- Average sales price of homes delivered of $676,000 compared to. -- Homebuilding gross margin percentage of 18.0% compared to 20.8%.Excluding inventory-related charges of $19.7 million, our homebuilding. -- Excluding interest and impairments and lot option abandonments,-- SG&A expense as a percentage of home sales revenue of 32.5% compared to. -- Loss before income taxes was $165.3 million compared to income before. of availability under our revolving credit facility*  See \"Reconciliation of Non-GAAP Financial Measures\"About Tri Pointe Homes, Inc.One of the largest homebuilders in the U.S., Tri Pointe Homes, Inc. has a presence in 13 st","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLS.SI","BK4022","SRU.SI","BK4604","03160","BK4232","SRT.SI","CLR.SI","BK4555","BK4585","BK4588","CFA.SI","BK4099","TM","R","JJJ.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162435","title":"Press Release: Xos Extends Gross Profit Streak, Highlighting Operational Efficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162435","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162435?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:10","pubTimestamp":1786651800,"startTime":"0","endTime":"0","summary":"revenue in the second quarter, compared to 135 units and $18.4 million in. Q2 2025, as the Company continued its strategic focus on powertrain and. -- Gross margins improved to 12.1%, compared to 8.9% in Q2 2025. Non-GAAP. gross margin improved to 7.2%, compared to 1.5% in Q2 2025, reflecting. the Company's continued inventory discipline and a more favorable product. -- Operating loss increased to $7.9 million in Q2 2026, compared to $7.1. million in Q2 2025 while Non-GAAP operating loss improved 9.5%. year-over-year to $6.2 million in Q2 2026, compared to $6.8 million in Q2. -- Second quarter operating expenses were $8.5 million in Q2 2026, down 2.1%. year-over-year and down 5.4% sequentially from Q1 2026. The reduction. reflects continued operational efficiency and cost discipline across the. under its at-the-market offering program and its registered direct. reinforcing liquidity and providing additional capital to support. revenue in the first half of 2026, compared to 164 units an","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","TSLW","TSLT","XOS","BK4099","03160","BK4149","TSII","TSLG","TSDD","TSLI","09766","TSLS","TLA","TSYY","09366","TSLY","TSLQ","CRSH","BK4588","07366","TESL","BK4555","ELOL","TM","TSLZ","BK4604","TSL","TEST","TSLO","TSLP","TSLL","TSLR","07766"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162466","title":"Press Release: Celcuity Inc. Reports Release of Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162466","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162466?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:06","pubTimestamp":1786651560,"startTime":"0","endTime":"0","summary":"-- REVTORPYK  approved by the U.S. FDA for the treatment of. HR+/HER2- PIK3CA Wild-Type locally advanced or metastatic breast cancer. on July 14, 2026; on track for commercial launch late third quarter 2026. -- NCCN Clinical Practice Guidelines recommended REVTORPYK in combination. with fulvestrant, with or without palbociclib, as a preferred Category 1. option for second-line therapy in HR+/HER2- advanced breast cancer. -- The Phase 3 PIK3CA mutant cohort of the VIKTORIA-1 trial achieved its. primary endpoint by doubling the likelihood of survival without disease. progression or death compared to alpelisib plus fulvestrant; a. supplemental New Drug Application  is planned for submission in","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","BK4139","BK4585","R","BK4588","03160","BK4022","BK4099","BK4555","BK4604","BK4232","CELC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659959162","title":"Press Release: Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus(TM) Development Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659959162","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659959162?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"Company updates anticipated commercial launch of Proteus to Q2 2027, cost-reduction actions expected to extend cash runway into Q4 2028 and highlights estimated new market opportunities for protein sequencingBRANFORD, Conn., Aug. 13, 2026  -- Quantum-Si Incorporated  , a proteomics technology company redefining protein analysis through single-molecule protein sequencing, today announced financial results for the second quarter ended June 30, 2026.Press Release Highlights-- Reported second quarter 2026 revenue of $344 thousand during the Proteus. -- Updated anticipated Proteus launch timeline to Q2 2027 to incorporate an. additional integrated instrument design cycle focused on manufacturing. readiness, system repeatability, and customer experience at launch.-- Highlighted an estimated $4 billion non-human proteomics market. -- Announced a reduction in force of approximately 20% of the Company's. workforce to align resources and spending with the updated Proteus launch","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","QSI","BK4121","BK4604","03160","BK4585","TM","BK4588","BK4099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659816250","title":"Press Release: Swarmer Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659816250","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659816250?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"contracted license value from $2.9 million to $3.9 million. Existing. customer upgrade options, if fully exercised, would bring the maximum. -- Partnered with Oak Grove Technologies to integrate Swarmer's autonomy. software into the Chimera UAV platform, advancing autonomous swarming. capabilities for U.S. Special Operations and defense missions.-- Signed an MOU with Powerus to explore the integration of Swarmer's. autonomy and swarming software across air and maritime autonomous. -- Collaborated with Lantronix to develop a custom NDAA-compliant compute. platform for Group 1 unmanned aerial systems, increasing onboard. -- Partnered with Brightline Interactive to integrate Swarmer's autonomy. software with Brightline's platform and expand access to operational data. -- Established a strategic data partnership with Molfar Intelli","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VGT","BK4604","BK4555","BK4588","BK4187","03160","BK4099","IGM","QQH","BK4585","TM","SWMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659629201","title":"Press Release: Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659629201","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659629201?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"All participants successfully dosed in SLIM-1(TM), the Company's first-in-human Phase 1 trial of NPM-139, a miniature, ultra long-acting semaglutide implant for chronic weight management; top-line dat","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4588","TM","03160","BK4232","BK4099","CRGT","R","BK4555","BK4604","BK4022","BK4585","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659216257","title":"Press Release: Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2659216257","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659216257?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"Total net revenue increased 14% to $18.7 million for second quarter of 2026 compared to second quarter of 2025Partnered programs continue to advance with Crystalys Therapeutics announcing its $130 mil","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4099","TM","HELS","BK4581","BK4022","BK4007","BK4604","R","BK4585","BK4588","DERM","FBIO","XBI","BK4139","BK4555","03160"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}